| Literature DB >> 30651987 |
Clémence Palazzo1,2, Renata T C Yokota2,3, Jean Tafforeau2, Jean-François Ravaud4, Emmanuelle Cambois5, Serge Poiraudeau6, Herman Van Oyen2,7, Wilma J Nusselder1.
Abstract
BACKGROUND: This study aimed 1) to assess whether the contribution of chronic conditions to disability varies according to the educational attainment, 2) to disentangle the contributions of the prevalence and of the disabling impact of chronic conditions to educational disparities.Entities:
Keywords: Chronic diseases; Disability; Educational attainment; Socioeconomic status
Year: 2019 PMID: 30651987 PMCID: PMC6330417 DOI: 10.1186/s13690-018-0326-9
Source DB: PubMed Journal: Arch Public Health ISSN: 0778-7367
Fig. 1Prevalence of disability according to age groups and educational level for men and women
Age-standardized prevalence and disabling impact of chronic conditions by educational level and gender, the Disability-Health survey, France, 2008–2009 (N = 23,348 respondents 25 years and older)
| Primary | Secondary | Tertiary | ||||
|---|---|---|---|---|---|---|
| Prevalencea, | Disabling impactb, mean (95% CI) | Prevalencea, | Disabling impactb, mean (95% CI) | Prevalencea, | Disabling impactb, (mean, 95% CI) | |
| Men | ||||||
| Spine disorders | 21.35 (20.23–22.52) | 0.28 (0.19–0.36) | 18.47 (17.46–19.53) | 0.18 (0.13–0.23) | 15.78 (14.14–17.57) | 0.15 (0.09–0.21) |
| Arthritis | 21.05 (19.99–22.15) | 0.46 (0.35–0.57) | 17.71 (16.67–18.79) | 0.53 (0.42–0.63) | 11.99 (10.53–13.62) | 0.38 (0.24–0.52) |
| Dementia | 1.51 (1.29–1.75) | 0.89 (0.25–1.53) | 1.55 (1.23–1.96) | 0.62 (−0.01–1.25) | 1.30 (0.87–1.95) | 3.28 (− 0.56–7.12) |
| Stroke | 2.61 (2.31–2.95) | 0.85 (0.37–1.32) | 2.46 (2.12–2.86) | 0.76 (0.34–1.17) | 1.79 (1.32–2.43) | 0.41 (− 0.07–0.89) |
| Other neurologic diseases | 2.15 (1.88–2.45) | 0.99 (0.47–1.50) | 2.04 (1.76–2.36) | 1.08 (0.61–1.55) | 1.32 (1.02–1.70) | 0.47 (0.10–0.85) |
| Ischemic heart diseases/PAD | 9.93 (9.22–10.69) | 0.83 (0.62–1.05) | 9.37 (8.56–10.26) | 0.57 (0.38–0.76) | 6.05 (4.99–7.32) | 0.64 (0.32–0.96) |
| Other heart diseases | 6.28 (5.75–6.85) | 0.61 (0.33–0.88) | 6.38 (5.74–7.07) | 0.29 (0.11–0.46) | 5.65 (4.54–7.01) | 0.31 (0.09–0.53) |
| COPD | 10.10 (9.37–10.89) | 0.42 (0.27–0.57) | 7.67 (6.98–8.43) | 0.28 (0.17–0.38) | 5.51 (4.55–6.65) | 0.14 (0.02–0.26) |
| Psychiatric diseases | 7.79 (7.18–8.45) | 0.65 (0.43–0.87) | 4.85 (4.42–5.33) | 0.54 (0.38–0.71) | 5.02 (4.24–5.92) | 0.36 (0.17–0.54) |
| Sensorial diseases | 0.96 (0.76–1.20) | 0.46 (−0.03–0.96) | 1.49 (1.15–1.92) | 0.18 (−0.11–0.47) | 0.45 (0.29–0.71) | 0.09 (− 0.19–0.38) |
| Cancer | 3.37 (2.97–3.82) | 0.66 (0.37–0.95) | 3.11 (2.64–3.66) | 0.38 (0.15–0.61) | 1.92 (1.45–2.56) | 0.49 (0.12–0.85) |
| Diabetes | 10.69 (9.95–11.47) | 0.20 (0.09–0.31) | 7.23 (6.56–7.97) | 0.13 (0.04–0.23) | 5.15 (4.28–6.18) | 0.16 (0.01–0.30) |
| Accidents | 5.37 (4.84–5.94) | 0.96 (0.62–1.29) | 4.59 (4.16–5.07) | 0.61 (0.44–0.78) | 3.29 (2.64–4.10) | 0.45 (0.22–0.69) |
| Women | ||||||
| Spine disorders | 23.00 (22.10–23.93) | 0.33 (0.25–0.41) | 23.08 (21.99–24.21) | 0.30 (0.24–0.35) | 22.32 (20.54–24.21) | 0.13 (0.08–0.18) |
| Arthritis | 29.95 (28.95–30.97) | 0.55 (0.47–0.64) | 23.77 (22.65–24.93) | 0.43 (0.36–0.51) | 21.03 (19.14–23.06) | 0.34 (0.23–0.45) |
| Dementia | 1.31 (1.16–1.47) | 1.44 (0.79–2.09) | 0.82 (0.65–1.04) | 1.22 (0.24–2.20) | 0.53 (0.29–0.96) | 3.00 (−3.34–9.35) |
| Stroke | 1.91 (1.72–2.13) | 0.79 (0.35–1.22) | 1.37 (1.12–1.68) | 1.76 (0.72–2.80) | 1.74 (1.22–2.46) | 1.15 (0.07–2.23) |
| Other neurologic diseases | 2.12 (1.88–2.39) | 1.23 (0.66–1.79) | 1.45 (1.25–1.69) | 1.20 (0.67–1.72) | 1.66 (1.31–2.10) | 0.79 (0.35–1.23) |
| Ischemic heart diseases/PAD | 3.74 (3.45–4.06) | 0.94 (0.61–1.27) | 3.22 (2.78–3.73) | 0.80 (0.41–1.20) | 3.44 (2.49–4.75) | 0.34 (−0.16–0.83) |
| Other heart diseases | 6.16 (5.74–6.59) | 0.75 (0.53–0.97) | 4.82 (4.32–5.37) | 0.34 (0.15–0.53) | 6.94 (5.64–8.51) | 0.48 (0.16–0.81) |
| COPD | 8.15 (7.61–8.71) | 0.22 (0.10–0.33) | 7.44 (6.81–8.12) | 0.35 (0.25–0.45) | 7.36 (6.20–8.72) | 0.35 (0.22–0.48) |
| Psychiatric diseases | 12.92 (12.25–13.61) | 0.44 (0.32–0.57) | 9.09 (8.49–9.73) | 0.34 (0.24–0.44) | 7.90 (6.92–9.00) | 0.23 (0.11–0.34) |
| Sensorial diseases | 0.56 (0.45–0.69) | 1.14 (0.31–1.96) | 0.39 (0.29–0.52) | 0.84 (0.04–1.64) | 0.65 (0.43–0.99) | 0.50 (−0.27–1.28) |
| Cancer | 2.98 (2.65–3.35) | 0.90 (0.59–1.22) | 2.49 (2.15–2.88) | 1.08 (0.72–1.44) | 3.72 (2.83–4.86) | 1.46 (0.82–2.10) |
| Diabetes | 8.43 (7.94–8.95) | 0.38 (0.25–0.51) | 4.79 (4.28–5.34) | 0.29 (0.15–0.44) | 2.19 (1.64–2.93) | 0.43 (0.03–0.83) |
| Accidents | 3.22 (2.89–3.60) | 0.28 (0.06–0.50) | 3.30 (2.92–3.73) | 0.53 (0.31–0.74) | 3.85 (3.12–4.74) | 0.93 (0.56–1.31) |
CI Confidence interval; Prevalence rates are weighted and age-standardized to the French population of men and women estimated by the 2009 census (French National Institute of Statistics and Economic Studies). The disabling impact is the disease-specific cumulative rates of disability for each disease (that is the β in the linear predictor presented in formula (1)). Spine disorders (low back pain, neck pain, spine deformity), arthritis (rheumatoid arthritis, other type of inflammatory arthritis, osteoarthritis), Parkinson and Alzheimer diseases (and other types of dementia), neurologic diseases (epilepsy, multiple sclerosis), stroke, ischemic heart disease/peripheral artery disease (PAD), other heart diseases (arrhythmia, heart failure), chronic obstructive pulmonary diseases (COPD) (asthma, chronic bronchitis), psychiatric diseases (anxiety, depression, schizophrenia and autism), sensorial diseases (blindness or severe visually impairment, deafness or serious hearing loss), cancer, diabetes, and sequelae of injury
Absolute contributions of diseases to educational disparity in disability prevalence in baseline situation and under counterfactual scenarios, the Disability Health Survey, France, 2008–2009. Results are % (95% CI)
| Contributions of Diseases to Total Prevalence of Disability | Difference Between Elementary and Tertiary Education | ||||||
|---|---|---|---|---|---|---|---|
| Primary (1) | Tertiary (2) | Primary, counterfactual with disease prevalence of tertiary (3) | Primary, counterfactual with disabling Impact of Tertiary (4) | Baseline Situation (No Counterfactual) (1–2) | Counterfactual With Disease Prevalence of primary Equal to Tertiary (3–2) a | Counterfactual with disabling Impact of primary equal to tertiary (4–2) b | |
| Men | |||||||
| Spine disorders | 3.8 (3.6–4.0) | 1.9 (1.8–2.1) | 3.2 | 2.3 | 1.9 | 1.3 | 0.4 |
| Arthritis | 5.7 (5.4–6.0) | 3.3 (3.0–3.9) | 3.4 | 5.3 | 2.4 | 0.1 | 2.0 |
| Dementia | 0.6 (0.6–0.6) | 1.2 (0.9–1.6) | 0.5 | 1.2 | −0.6 | − 0.7 | 0.0 |
| Stroke | 1.0 (0.9–1.0) | 0.5 (0.5–0.6) | 0.7 | 0.6 | 0.5 | 0.2 | 0.1 |
| Neurologic diseases | 1.0 (0.9–1.0) | 0.4 (0.4–0.4) | 0.7 | 0.6 | 0.6 | 0.3 | 0.2 |
| Ischemic heart diseases/PAD | 4.1 (3.9–4.3) | 2.4 (2.2–3.0) | 2.8 | 3.7 | 1.7 | 0.4 | 1.3 |
| Other heart diseases | 1.8 (1.7–1.9) | 1.3 (1.1–1.7) | 2.0 | 1.2 | 0.5 | 0.7 | −0.1 |
| COPD | 2.4 (2.3–2.6) | 0.6 (0.5–0.7) | 1.5 | 1.0 | 1.8 | 0.9 | 0.4 |
| Psychiatric diseases | 2.6 (2.5–2.8) | 1.2 (1.1–1.3) | 1.6 | 1.8 | 1.4 | 0.4 | 0.6 |
| Sensorial diseases | 0.3 (0.3–0.3) | 0.0 (0.0–0.0) | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 |
| Cancer | 1.2 (1.1–1.2) | 0.6 (0.6–0.8) | 0.7 | 1.0 | 0.6 | 0.1 | 0.4 |
| Diabetes | 1.4 (1.4–1.5) | 0.7 (0.7–0.8) | 0.9 | 1.2 | 0.7 | 0.2 | 0.5 |
| Accidents | 2.4 (2.3–2.5) | 1.0 (0.9–1.1) | 1.2 | 1.5 | 1.4 | 0.2 | 0.5 |
| Background | 10.7 (10.2–11.3) | 5.7 (5.3–6.4) | 11.6 | 11.4 | 5.0 | 5.9 | 5.7 |
| Disability prevalence | 38.9 (37.3–41.0) | 20.9 (19.2–24.0) | 30.8 | 32.8 | 18 | 9.9 | 11.9 |
| Women | |||||||
| Spine disorders | 4.5 (4.3–4.7) | 2.1 (1.9–2.3) | 4.5 | 2.0 | 2.4 | 2.4 | −0.1 |
| Arthritis | 9.5 (9.1–9.9) | 4.5 (4.1–5.2) | 7.0 | 6.6 | 5.0 | 2.5 | 2.1 |
| Dementia | 0.7 (0.7–0.8) | 0.4 (0.3–0.5) | 0.5 | 1.0 | 0.3 | 0.1 | 0.6 |
| Stroke | 0.7 (0.6–0.7) | 0.8 (0.7–1.1) | 0.8 | 1.2 | −0.1 | 0.0 | 0.4 |
| Neurologic diseases | 1.1 (1.0–1.2) | 0.7 (0.7–0.8) | 0.8 | 0.9 | 0.4 | 0.1 | 0.2 |
| Ischemic heart diseases/PAD | 1.5 (1.4–1.6) | 0.7 (0.6–0.8) | 1.5 | 0.7 | 0.8 | 0.8 | 0.0 |
| Other heart diseases | 2.2 (2.1–2.3) | 1.8 (1.6–2.3) | 2.9 | 1.7 | 0.4 | 1.1 | −0.1 |
| COPD | 1.1 (1.0–1.1) | 1.8 (1.6–2.1) | 1.0 | 1.8 | −0.7 | −0.8 | 0.0 |
| Psychiatric diseases | 3.1 (3.0–3.3) | 1.1 (1.0–1.3) | 1.9 | 1.9 | 2.0 | 0.8 | 0.8 |
| Sensorial diseases | 0.3 (0.3–0.3) | 0.2 (0.2–0.2) | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Cancer | 1.4 (1.3–1.5) | 2.2 (2.0–2.6) | 1.5 | 1.9 | −0.8 | −0.7 | −0.3 |
| Diabetes | 1.8 (1.8–1.9) | 0.6 (0.5–0.7) | 0.4 | 2.2 | 1.2 | −0.2 | 1.6 |
| Accidents | 0.5 (0.5–0.6) | 1.7 (1.5–1.9) | 0.8 | 1.5 | −1.2 | −0.9 | − 0.2 |
| Background | 14.0 (13.5–14.6) | 11.1 (9.7–13.9) | 14.3 | 14.7 | 2.9 | 3.2 | 3.6 |
| Disability prevalence | 42.3 (40.9–44.1) | 29.7 (26.7–35.2) | 38.0 | 37.8 | 12.6 | 8.3 | 8.1 |
aThis represents the part of educational disparity explained by the difference of disabling impact of diseases between the primary and the tertiary educational level group
bThis represents the part of educational disparity explained by the difference of diseases prevalence between the primary and the tertiary educational level group
PAD Peripheral Artery Diseases, COPD Chronic Obstructive Pulmonary Diseases
Contributions were age-standardized to the French population of men and women estimated by the 2009 census (French National Institute of Statistics and Economic Studies). There were 23,348 respondents 25 years and older
Fig. 2Age-standardized absolute contribution of chronic conditions and background to the prevalence of disability according to educational level